Prevention and management of infections associated with combat-related thoracic and abdominal cavity injuries

Journal of Trauma - Injury, Infection and Critical Care

Volumn 64, Issue SUPPL. 3, 2008, Pages

  Conger, Nicholas G ^a   Landrum, Michael L ^b,c   Jenkins, Donald H ^d   Martin, R Russell ^e   Dunne, James R ^f   Hirsch, Erwin F ^g  

^a LANDSTUHL REGIONAL MEDICAL CENTER   (Germany)

^b SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d WILFORD HALL MEDICAL CENTER   (United States)

^e BROOKE ARMY MEDICAL CENTER   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abdomen; Combat; Infection; Thorax; Trauma

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CARBAPENEM DERIVATIVE; CEFALOTIN; CEFAZOLIN; CEFOPERAZONE; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; KANAMYCIN; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; SULTAMICILLIN; TIMENTIN;

ABDOMINAL INJURY; ANTIMICROBIAL THERAPY; BATTLE INJURY; CONFERENCE PAPER; DEBRIDEMENT; EVIDENCE BASED MEDICINE; INFECTION; INFECTION PREVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; THORAX INJURY; WOUND CLOSURE; WOUND IRRIGATION; HUMAN; MILITARY MEDICINE; REVIEW; WAR; WOUND INFECTION;

ABDOMINAL INJURIES; HUMANS; MILITARY MEDICINE; THORACIC INJURIES; WAR; WOUND INFECTION;

EID: 43149097639     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318163d2c8     Document Type: Conference Paper

References (73)

1. Burris DG, FitzHarris JB, Holcomb JB, et al. Emergency War Surgery: Third United States Revision. Washington, DC: Borden Institute; 2004.
2. Johnson J. Battle wounds of the thoracic cavity. Ann Surg. 1946;123:321-342.
3. Montgomery H, Halberslend D, Carr FP. Puncture wounds of the chest. J Thor Surg. 1947;47:407-415.
4. Luchette FA, Barie PS, Oswanski MF, et al. Practice management guidelines for prophylactic antibiotic use in tube thoracostomy for traumatic hemopneumothorax: The EAST practice management guidelines work group. J Trauma. 2000;48:753-759.
5. Zouris JM, Walker GJ, Dye J, Galarneau M. Wounding patterns for U.S. marines and sailors during Operation Iraqi Freedom, major combat phase. Mil Med. 2006;171:246-252.
6. Cho JM, Jatoi I, Alarcon AS, Morton TM. Operation Iraqi Freedom: surgical experience of the 212th mobile army surgical hospital. Mil Med. 2005;170:268-272.
7. Mabry RL, Holcomb JB, Baker AM, et al. United States army rangers in Somalia: an analysis of combat casualties on an urban battlefield. J Trauma. 2000;49:515-529.
8. Peterson K, Riddle MS, Danko JR, et al. Trauma-related infections in battlefield casualties from Iraq. Ann Surg. 2007;245:803-811.
9. Wallace C. A study of 1,200 cases of gunshot wounds of the abdomen. BMJ. 1916;4:679.
10. Fraser J, Drummond H. Three hundred perforating wounds of the abdomen. BMJ. 1917;X:321.
11. Ogilvie WH. Abdominal wounds in the western desert. Surg Gynecol Obstet. 1944;78:225.
12. Imes PR. War surgery of the abdomen. Surg Gynecol Obstet. 1945;81:608-616.
13. Fullen WD, Hunt J, Altemeier WA, et al. Prophylactic antibiotics in penetrating wounds of the abdomen. J Trauma. 1972;137:270-276.
14. Thadepalli H, Gorbach SL, Broido PW, et al. Abdominal trauma, anaerobes, and antibiotics. Surg Gynecol Obstet. 1973;137:270-276.
15. Steele SR, Wolcott KE, Mullenix PS, et al. Colon and rectal injuries during Operation Iraqi Freedom: are there any changing trends in management outcome? Dis Colon Rectum. 2007;50:870-877.
16. Yun HC, Murray CK, Roop SA, et al. Bacteria recovered from patients admitted to a deployed U.S. military hospital in Baghdad, Iraq. Mil Med. 2006;171:821-825.
17. Bozorgzadeh A, Pizzi WF, Barie PS, et al. The duration of antibiotic administration in penetrating abdominal trauma. Am J Surg. 1999;177:125-131.
18. Kirton OC, O'Neill PA, Kestner MM, Tortella BJ. Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days. J Trauma. 2000;49:822-832.
19. Delgado G, Barletta JF, Kanji S, et al. Characteristics of prophylactic antibiotic strategies after penetrating abdominal trauma at a level I urban trauma center: a comparison with the EAST guidelines. J Trauma. 2002;53:673-678.
20. Tyburski JG, Wilson RF, Warsow KM, McCreadie S. A trial of ciprofloxacin and metronidazole vs gentamicin and metronidazole for penetrating abdominal trauma. Arch Surg. 1998;133:1289-1296.
21. O'Neill PA, Kirton OC, Dresner LS, et al. Analysis of 162 colon injuries in patients with penetrating abdominal trauma: concomitant stomach injury results in a higher rate of infection. J Trauma. 2004;56:304-313.
22. Tyburski JG, Dente CJ, Wilson RF, et al. Infectious complications following duodenal and/or pancreatic trauma. Am Surg. 2001;67:227-230.
23. Solomkin JS, Mazuski JE, Baron EJ, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37:997-1005.
24. Babinchak T, Ellis-Grosse E, Dartois N, et al. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis. 2005;41:s354-s367.
25. Montravers P, Gauzit R, Muller C, et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis. 1996;23:486-494.
26. Virgilio RW. Intrathoracic wounds in battle casualties. Surg Gynecol Obstet. 1970;130:609-615.
27. Coselli JS, Mattox KL, Beal AC. Reevaluation of early evacuation of clotted hemothorax. Am J Surg. 1984;148:786-790.
28. Valle AR. An analysis of 2811 chest casualties of the Korean conflict. Chest. 1954;26:623-633.
29. Mandal AK, Thadepalli H, Mandal AK, Chettipalli U. Posttraumatic empyema thoracis: a 24-year experience at a major trauma center. J Trauma. 1997;43:764-771.
30. Maxwell RA, Campbell DJ, Fabian TC, et al. Use of presumptive antibiotics following tube thoracostomy for traumatic hemopneumothorax in the prevention of empyema and pneumonia - a multi-center trial. J Trauma. 2004;57:742-749.
31. Sanabria A, Valdivieso E, Gomez G, Echeverry G. Prophylactic antibiotics in chest trauma: a meta-analysis of high-quality studies. World J Surg. 2006;30:1843-1847.
32. Aguilar MM, Battistella FD, Owings JT, Su T. Posttraumatic empyema: risk factor analysis. Arch Surg. 1997;132:647-651.
33. Antonelli M, Moro ML, Capelli O, et al. Risk factors for early onset pneumonia in trauma patients. Chest. 1994;105:224-228.
34. Hoff SJ, Shotts SD, Eddy VA, et al. Outcome of isolated pulmonary contusion in blunt trauma patients. Am Surg. 1994;60:138-142.
35. Walker WE, Kapelanski DP, Weiland AP, et al. Patterns of infection and mortality in thoracic trauma. Ann Surg. 1985;201:752-757.
36. Luchette FA, Borzotta AP, Croce MA, et al. Practice management guidelines for prophylactic antibiotic use in penetrating abdominal trauma: the EAST practice management guidelines work group. J Trauma. 2000;48:501-513.
37. Fabian TC, Hess MM, Croce MA, et al. Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal trauma. Am J Surg. 1994;167:291-296.
38. Fabian TC, Hoefling SJ, Strom PR, Stone HH. Use of antibiotic prophylaxis in penetrating abdominal trauma. Clin Ther. 1982;5:38-47.
39. Jones RC, Thal ER, Johnson NA, Gollihar LN. Evaluation of antibiotic therapy following penetrating abdominal trauma. Ann Surg. 1985;201:576-585.
40. Sims EH, Thadepalli H, Ganesan K, Mandal AK. How many antibiotics are necessary to treat abdominal trauma victims? Am Surg. 1997;63:525-535.
41. Nichols RL, Smith JW, Klein DB, et al. Risk of infection after penetrating abdominal trauma. N Engl J Med. 1984;311:1065-1070.
42. Fabian TC, Croce MA, Payne LW, et al. Duration of antibiotic therapy for penetrating abdominal trauma: a prospective trial. Surg Gynecol Obstet. 1992;112:788-795.
43. Lou MA, Thadepalli H, Mandal AK. Safety and efficacy of mezlocillin: a single-drug therapy for penetrating abdominal trauma. J Trauma. 1988;28:1541-1547.
44. Ericsson CD, Fischer RP, Rowlands BJ, et al. Prophylactic antibiotics in trauma: the hazards of underdosing. J Trauma. 1989;29:1356-1361.
45. Moore FA, Moore EE, Ammons LA, McCroskey BL. Presumptive antibiotics for penetrating abdominal wounds. Surg Gynecol Obstet. 1989;169:99-103.
46. Cornwell EE, Dougherty WR, Berne TV, et al. Duration of antibiotic prophylaxis in high-risk patients with penetrating abdominal trauma: a prospective randomized trial. J Gastrointest Surg. 1999;3:648-653.
47. Velmahos G, Toutouzas KG, Sarkisyan G, et al. Severe trauma is not an excuse for prolonged antibiotic prophylaxis. Arch Surg. 2002;137:537-542.
48. Hoth JJ, Franklin GA, Stassen NA, et al. Prophylactic antibiotics adversely affect nosocomial pneumonia in trauma patients. J Trauma. 2003;55:249-254.
49. Dellinger EP. Antibiotic prophylaxis in trauma: penetrating abdominal injuries and open fractures. Rev Infect Dis. 1991;13:s847-s857.
50. Maxwell RA, Fabian TC. Current management of colon trauma. World J Surg. 2003;27:632-639.
51. Cayten CG, Fabian TC, Garcia VF, et al. EAST patient management guidelines for penetrating intraperitoneal colon injuries. J Trauma. 1998;44:941-956.
52. Malangoni MA, Dillon LD, Klamer TW, Condon RE. Factors influencing the risk of early and late serious infection in adults after splenectomy for trauma. Surgery. 1984;96:775-783.
53. Brigden ML, Pattullo AL. Prevention and management of overwhelming postsplenectomy infection - an update. Crit Care Med. 1999;27:836-842.
54. Howdieshell TR, Heffernan D, DiPiro JT. Surgical infection society guidelines for vaccination after traumatic injury. Surg Infect. 2006;7:275-303.
55. Schatz DV, Schinsky MF, Pais LB, et al. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy. J Trauma. 1998;44:760-766.
56. Schatz DV, Romero-Steiner S, Elie CM, et al. Antibody responses in postsplenectomy trauma patients receiving the 23-valent pneumococcal polysaccharide vaccine at 14 versus 28 days postoperatively. J Trauma. 2002;53:1037-1042.
57. Spanjersberg W, Ringberg A, Bergs B, et al. Prehospital chest tube thoracostomy: effective treatment or additional trauma. J Trauma. 2005;59:96-101.
58. Grover FL, Richardson JD, Fewel JG, et al. Prophylactic antibiotics in the treatment of penetrating chest wounds. A prospective double-blind study. J Thorac Cardiovasc Surg. 1977;74:975-977.
59. Stone HH, Symbas PN, Hooper CA. Cefamandole for prophylaxis against infection in closed thoracostomy. J Trauma. 1981;21:975-977.
60. Cant PJ, Smyth S, Smart DO. Antibiotic prophylaxis is indicated for chest stab wounds requiring closed thoracostomy. Br J Surg. 1993;80:464-466.
61. Nichols RL, Smith JW, Muzik AC, et al. Preventive antibiotic usage in traumatic thoracic injuries requiring closed thoracostomy. Chest. 1994;106:1493-1498.
62. Gonzalez RP, Holevar MR. Role of prophylactic antibiotics for tube thoracostomy in chest trauma. Am Surg. 1998;64:617-621.
63. Malangoni MA, Song J, Herrington J, et al. Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxacillin-clavulanate for the treatment of complicated intra-abdominal infections. Ann Surg. 2006;244:204-211.
64. Solomkin JS, Yellin AE, Rotstein OD, et al. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg. 2003;237:235-245.
65. Solomkin JS, Reinhart HH, Dellinger EP, et al. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. Ann Surg. 1996;223:303-315.
66. Solomkin JS, Wilson SE, Christou NV, et al. Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. Ann Surg. 2001;233:79-87.
67. Aldredge KE, O'Brien M. In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data. J Clin Microbiol. 2002;40:4349-4352.
68. Snydman DR, Jacobus NV, McDermott LA, et al. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob Agents Chemother. 1999;43:2417-2422.
69. Calandra T, Bille J, Schneider R, et al. Clinical significance of candida isolated from peritoneum in surgical patients. Lancet. 1989;2:1437-1439.
70. Kumar RR, Kim JT, Haukoos JS, et al. Factors affecting the successful management of intra-abdominal abscesses with antibiotics and the need for percutaneous drainage. Dis Colon Rectum. 2006;49:183-189.
71. Lawrence DR, Ohri SK, Moxon RE, et al. Thoracoscopic debridement of empyema thoracis. Ann Thorac Surg. 1997;64:1448-1450.
72. Navsaria PH, Vogel RJ, Nicol AJ. Thoracoscopic evacuation of retained posttraumatic hemothorax. Ann Thorac Surg. 2004;78:282-285.
73. Wurnig PN, Wittmer V, Prindun NS, et al. Video-assisted thoracic surgery for pleural empyema. Ann Thorac Surg. 2006;81:309-313.